Maha Salma

Prof. Dr. Maha Salma


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DEDina M. El-Kersh
Dina M. El-Kersh
SEShahira M. Ezzat
Shahira M. Ezzat
MSMaha Salma
Maha Salma
EMEngy A. Mahrous
Engy A. Mahrous
YAYasmeen M. Attia
Yasmeen M. Attia
MEMohey M. Elmazar
Mohey M. Elmazar
Estrogen signaling is crucial for breast cancer initiation and progression. Endocrine-based therapies comprising estrogen receptor (ER) modulators and aromatase inhibitors remain the mainstay of treatment. This study aimed at investigating the antitumor potential of the most potent compounds in citrus peels on breast cancer by exploring their anti-estrogenic and anti-aromatase activities. The ethanolic extract of different varieties of citrus peels along with eight isolated flavonoids were screened against estrogen-dependent breast cancer cell lines besides normal cells for evaluating their safety profile. Naringenin, naringin and quercetin demonstrated the lowest IC50sand were therefore selected for further assays. In silico molecular modeling against ER and aromatase was performed for the three compounds. In vivo estrogenic and anti-estrogenic assays confirmed an anti-estrogenic activity for the isolates. Moreover, naringenin, naringin and quercetin demonstrated in vitro inhibitory potential against aromatase enzyme along with anticancer potential in vivo, as evidenced by decreased tumor volumes. Reduction in aromatase levels in solid tumors was also observed in treated groups. Overall, this study suggests an antitumor potential for naringenin, naringin and quercetin isolated from citrus peels in breast cancer via possible modulation of estrogen signaling and aromatase inhibition suggesting their use in pre- and post-menopausal breast cancer patients, respectively.

1 October 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
SEShahira M. Ezzat
Shahira M. Ezzat
HAHeba M.I. Abdallah
Heba M.I. Abdallah
NYNoha N. Yassen
Noha N. Yassen
RRRasha A. Radwan
Rasha A. Radwan
EMEman Mostafa
Eman Mostafa
Dr.Mohamed Fathy SalemDr.Mohamed Fathy Salem
Dr.Mohamed Fathy Salem
The objective of our study was to evaluate the effect of Physalis peruviana L. fruits in the management of diabetes and diabetic nephropathy in relation to its metabolic profile. In-vitro α-amylase, β-glucosidase, and lipase inhibition activities were assessed for the ethanolic extract (EtOH) and its subfractions. Ethyl acetate (EtOAc) fraction showed the highest α-amylase, β-glucosidase, and lipase inhibition effect. In vivo antihyperglycemic testing of EtOAc in streptozotocin (STZ)-induced diabetic rats showed that it decreased the blood glucose level, prevented the reduction in body weight, improved serum indicators of kidney injury (urea, uric acid, creatinine), and function (albumin and total protein). EtOAc increased autophagic parameters (LC3B, AMPK) and depressed mTOR contents. Histopathology revealed that EtOAc ameliorated the pathological features and decreased the glycogen content induced by STZ. The immunohistochemical analysis showed that EtOAc reduced P53 expression as compared to the STZ-diabetic group. UPLC-ESI-MS/MS metabolite profiling of EtOAc allowed the identification of several phenolic compounds. Among the isolated compounds, gallic acid, its methylated dimer and the glycosides of quercetin had promising α-amylase and β-glucosidase inhibition activity. The results suggest that the phenolic-rich fraction has a protective effects against diabetic nephropathy presumably via enhancing autophagy (AMPK/mTOR pathway) and prevention of apoptosis (P53 suppression).

1 July 2020 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
RRRasha A. Radwan
Rasha A. Radwan
YEYoussef A. El-Sherif
Youssef A. El-Sherif
MSMaha Salma
Maha Salma

21 July 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
Dr.Mohamed Fathy SalemDr.Mohamed Fathy Salem
Dr.Mohamed Fathy Salem
NANora Mohamed Aborehab
Nora Mohamed Aborehab
MAMai M. Abdelhafez
Mai M. Abdelhafez
Sameh Hamed IsmailSameh Hamed Ismail
Sameh Hamed Ismail
NMNadine W. Maurice
Nadine W. Maurice
SEShahira M. Ezzat
Shahira M. Ezzat
White, green, and oolong teas are produced from the tea plant (Camellia sinensis (L.) Kuntze) and are reported to have anti-obesity and hypolipidemic effects. The current study aims to investigate the anti-obesity effects of a tea mixture nano-formulation by targeting the AMPK/Sirt-1/GLUT-4 axis in rats. In vitro lipase and α-amylase inhibition assays were used to determine the active sample, which was then incorporated into a nanoparticle formulation subjected to in vivo anti-obesity testing in rats by measuring the expression level of different genes implicated in adipogenesis and inflammation using qRT-PCR. Moreover, metabolomic analysis was performed for each tea extract using LC/ESI MS/MS coupled to chemometrics in an attempt to find a correlation between the constituents of the extracts and their biological activity. The in vitro pancreatic lipase and α-amylase inhibition assays demonstrated more effective activity in the tea mixture than the standards, orlistat and acarbose, respectively, and each tea alone. Thus, the herbal tea mixture and its nanoparticle formulation were evaluated for their in vivo anti-obesity activity. Intriguingly, the tea mixture significantly decreased the serum levels of glucose and triglycerides and increased the mRNA expression of GLUT-4, P-AMPK, Sirt-1, and PPAR-γ, which induce lipolysis while also decreasing the mRNA expression of TNF-α and ADD1/SREBP-1c, thereby inhibiting the inflammation associated with obesity. Our study suggests that the tea mixture nano-formulation is a promising therapeutic agent in the treatment of obesity and may also be beneficial in other metabolic disorders by targeting the AMPK/Sirt-1/Glut-4 pathway.

23 November 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Dr.Mohamed Fathy SalemDr.Mohamed Fathy Salem
Dr.Mohamed Fathy Salem
MSMaha Salma
Maha Salma
SEShahira M. Ezzat
Shahira M. Ezzat
YHYomna A. Hashem
Yomna A. Hashem
Enterococci are a common cause of urinary tract infections. The severity of enterococcal infections is associated with their ability to form biofilms. Morus leaves are known as a natural antibacterial, however, their antibiofilm activity against Enterococcus remains unveiled. This study aimed to evaluate the ability of four polyphenol-rich Morus leaves extracts (Morus nigra,M.rubra,M.macroura,andM.alba)to inhibit biofilm formed by enterococcal clinical isolates in relation to their metabolic profiling. Results revealed that 48% of the isolates formed strong biofilm, 28% formed moderate biofilm, 20% formed weak biofilm, and only 4% did not form a biofilm. The strong biofilm-forming isolates wereE. faecalis,and hence were chosen for this study.The antibiofilm activity of the four polyphenol-rich Morus leaves extracts revealed that theM.nigraextract exhibited the highest percentage of biofilm inhibition followed byM.rubrathenM.macrouraand the least inhibition was detected inM.alba,and these results were in accordance with the phenolic and flavonoid contents of each extract.UPLC-ESI-MS/MS identified 61 polyphenolic compounds in the four extracts. Further, multivariate analysis confirmed clear segregation ofM. nigrafrom the other species suggesting disparity in its metabolome, with accumulation of flavonoids, anthocyanidins, phenolic acids and coumarin derivatives. Quercetin and kaempferol glycosides were found to be positively and significantly correlated to the antibiofilm activity. In conclusion,M. nigraethanolic extracts showed the highest phenolic content and antibiofilm activity and they could be developed as a complementary treatment for the development of antimicrobial agents.

6 May 2016 in Natural Product Research
Verified
Journal Article
Closed access
SEShahira M Ezzat
Shahira M Ezzat
MSMaha Salma
Maha Salma
EMEngy A Mahrous
Engy A Mahrous
LMLouis Maes
Louis Maes
CPCheol-Ho Pan
Cheol-Ho Pan
Essam Abdel-SattarEssam Abdel-Sattar
Essam Abdel-Sattar
The bioactive petroleum ether fraction of Verbesina encelioides, previously studied by the authors, was chosen for the isolation of antiprotozoal metabolites. Pseudotaraxasterol-3β-acetate (1), benzyl 2,6-dimethoxy benzoate (2), 16β-hydroxy-pseudotaraxasterol-3β-palmitate (3) and pseudotaraxasterol (4), in addition to β-sitosterol glucoside (5) and β-sitosterol galactoside (6) were isolated and identified based on one-dimensional and two-dimensional spectral analysis. This is the first report describing (3) and (6) in genus Verbesina. The isolated compounds were tested in vitro against Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi and Leishmania infantum. Cytotoxicity was evaluated on MRC-5 cells. Compound 1 showed moderate to weak activity against L. infantum T. brucei and P. falciparum and was inactive against T. cruzi. Compound 3 showed moderate activity against L. infantum, compound 4 revealed weak activity against T. cruzi, while 5 and 6 were inactive against all tested protozoa. All compounds were non-cytotoxic. The isolated constituents showed less antiprotozoal activity than the crude fraction.